ストックスクリーナーアプリを入手
0.00
100.00%
-0.2075
アフターアワーズ：
.28
0.28
+
Casi Pharmaceuticals Inc (CASI) 最新ニュース
Why Did CASI Stock Plummet 64% Today To Hit An All-Time Low? - Stocktwits
CASI Pharmaceuticals Director Resigns but Stays On as Consultant - TipRanks
CASI Pharmaceuticals (CASI) director Barbara Krebs-Pohl exits board, to consult - Stock Titan
CASI Pharmaceuticals Company Profile & Introduction - Moomoo
MSN Money - MSN
CASIF Stock: Wang Chunhua COO Option Filing May 22, 2026 - Meyka
CASI Pharmaceuticals (CASIF) Revenue BreakdownMain Composition - Moomoo
CASI Pharmaceuticals (CASI) holder reports 58.8% stake and $5M note - Stock Titan
CASI Pharmaceuticals Receives FDA Clearance On The Investigation - GuruFocus
CASI Pharmaceuticals (CASI) posts 2025 loss and flags going‑concern risk - Stock Titan
CASI Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
CASI Pharmaceuticals, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
CASIF Stock: Wang Chunhua COO Option Grant May 13, 2026 - Meyka
Number of shareholders of CASI Pharmaceuticals, Inc. – OTC:CASIF - TradingView
TradingKey - TradingKey
CASI Pharmaceuticals Inc. (CASIF) Cash From Financing (TTM) - Zacks Investment Research
CASIF Stock: Wang Chunhua COO Option Filing May 08, 2026 - Meyka
CASIF Stock: Wang Chunhua COO Option Filing May 05, 2026 - Meyka
CASI Pharmaceuticals Inc. (CASIF) Ps Ratio (TTM) - Zacks Investment Research
CASIF Stock: Wang Chunhua COO Option Filing May 01, 2026 - Meyka
CASIF Insider Filing: Wang Chunhua COO Option Grant April 2026 - Meyka
CASI Pharmaceuticals to be delisted from Nasdaq, shares to move to OTC market - MSN
CASI Pharmaceuticals (CASI) director reports fully vested option stakes - Stock Titan
CASIF Officer Wang Chunhua Files Initial Ownership, April 2026 - Meyka
CASI Pharmaceuticals Delays Annual 20-F Filing - TipRanks
Director Zeng lists CASI Pharmaceuticals (CASIF) fully vested option holdings - Stock Titan
CASI Pharmaceuticals Reshapes Medical Leadership Amid U.S. Streamlining Drive - TipRanks
CASI Pharmaceuticals, Inc. announced that it has received $20 million in funding from ETP Global III Fund LP - marketscreener.com
Leadership shift at CASI (NASDAQ: CASI) as Global CMO role ends - Stock Titan
CASI Pharmaceuticals Closes Final US$5 Million Tranche of US$20 Million Convertible Notes - TipRanks
CASI Pharmaceuticals (OTCQB: CASIF) completes final $5M convertible note - Stock Titan
Hai Huang Net Worth (2026) - GuruFocus
Kun Qian Net Worth (2026) - GuruFocus
Chunhua Wang Net Worth (2026) - GuruFocus
Wei R Gao Net Worth (2026) - GuruFocus
CASIF Insider Trade: Wang Chunhua COO Option Filing April 2026 - Meyka
CASI (CASIF) General Counsel discloses vested and performance-based stock options - Stock Titan
CASI Pharmaceuticals Begins Trading on OTCQB Under Ticker CASIF - TipRanks
CASI Pharmaceuticals (CASI) begins OTCQB trading of ordinary shares as CASIF - Stock Titan
CASI Pharmaceuticals (OTC: CASIF) controller reports multiple stock option grants - Stock Titan
CASIF Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
CASI Pharmaceuticals (CASIF) executive details 2034 stock option positions - Stock Titan
[Form 3] CASI Pharmaceuticals, Inc. Initial Statement of Beneficial Ownership - Stock Titan
CASI Pharmaceuticals (CASIF) CMO holds 116,333 fully vested options at $1.93 - Stock Titan
CASIF: CASI Pharmaceuticals Inc.Comparison to Industry - Zacks Investment Research
All News for CASIF : CASI Pharmaceuticals Inc. - Zacks Investment Research
CASI SEC FilingsCasi Pharmaceuticals Inc 10-K, 10-Q, 8-K Forms - Stock Titan
CASI Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Dividend HistoryCASI Pharmaceuticals Inc. (CASIF) - Zacks Investment Research
Aug Wrap: Can CASI Pharmaceuticals Inc maintain its current growth rate2026 Setups & Accurate Technical Buy Alerts - baoquankhu1.vn
1.13%
3.22%
大文字化:
|
ボリューム (24 時間):